Speaker illustration

Mr Shafeeq Ahmed Mohammed

University of Zurich, Zurich (Switzerland)

Member of:

European Society of Cardiology

A chromatin signature by the methyltransferase SETD7 orchestrates angiogenic response in diabetic limb ischemia

Event: ESC Congress 2022

Topic: Microcirculation, Angiogenesis, Arteriogenesis

Session: Metabolic control of angiogenesis

Thumbnail

Targeting Neurofibromin 2 (NF2) Prevents Endothelial Dysfunction in Obesity: A Study in Mice and Humans

Event: ESC Congress 2022

Topic: Signal Transduction, Mechanotransduction

Session: Metabolic syndrome and vascular dysfunction

Thumbnail

Pharmacological blockade of histone methyltransferase SETD7 restores angiogenic response in experimental diabetes

Event: ESC Congress 2021 - The Digital Experience

Topic: Genetics, Epigenetics, ncRNA

Session: Congress committee e-posters choice in basic science

Thumbnail

The BET protein inhibitor apabetalone (RVX-208) restores angiogenic response in type 1 and type 2 diabetes by transcriptional regulation of thrombospondin-1

Event: ESC Congress 2021 - The Digital Experience

Topic: Microcirculation, Angiogenesis, Arteriogenesis

Session: Basic science e-posters

Thumbnail

A chromatin signature by the methyltransferase SETD7 regulates semaphorin-3G transcription and angiogenic response in diabetes: insights for personalized epigenetic therapies

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Genetics, Epigenetics, ncRNA

Session: Genetics

Thumbnail

Histone marks induced by the methyltransferase SETD7 modulate angiogenic response in diabetes

Event: ESC CONGRESS 2019

Topic: Microcirculation, Angiogenesis, Arteriogenesis

Session: Platelets and coagulation

Thumbnail

ESC 365 is supported by

logo Novo Nordisk